Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 1;2(4):233-236.
doi: 10.1016/j.ijmyco.2013.09.002.

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen

Maham Farshidpour  1 , Golnaz Ebrahimi  2 , Mehdi Mirsaeidi  3
Affiliations

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen

Maham Farshidpour et al. Int J Mycobacteriol. .

Abstract

The following is a case of multidrug-resistant pulmonary tuberculosis (MDR-TB) that was treated successfully with a linezolid-containing regimen. It was found that linezolid is an efficient medicine for MDR-TB treatment with an acceptable side effect profile. Treatment was maintained for 18 months, and closely monitoring toxicities did not reveal evidence of any neurologic adverse effects. However, despite our expectation, thrombocytopenia was seen after 2 years follow-up.

Keywords: Linezolid; Multidrug-resistant tuberculosis; Thrombocytopenia; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

None.

References

    1. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1: Introduction and diagnosis of tuberculosis in children. Int J Tuberc Lung Dis. 2006;10(10):1091–1097. - PubMed
    1. Lillebaek T, Andersen AB, Bauer J, et al. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol. 2001;39(3):855–861. - PMC - PubMed
    1. Falzon D, Jaramillo E, Schunemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011;38(3):516–528. - PubMed
    1. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004;169(10):1103–1109. - PubMed
    1. Chang KC, Yew WW. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Respirology. 2013;18(1):8–21. - PubMed

LinkOut - more resources